Srikanth Talluri

1.1k total citations
48 papers, 701 citations indexed

About

Srikanth Talluri is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Srikanth Talluri has authored 48 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 24 papers in Hematology and 16 papers in Oncology. Recurrent topics in Srikanth Talluri's work include Multiple Myeloma Research and Treatments (24 papers), DNA Repair Mechanisms (11 papers) and Cancer-related Molecular Pathways (8 papers). Srikanth Talluri is often cited by papers focused on Multiple Myeloma Research and Treatments (24 papers), DNA Repair Mechanisms (11 papers) and Cancer-related Molecular Pathways (8 papers). Srikanth Talluri collaborates with scholars based in United States, India and Canada. Srikanth Talluri's co-authors include Frederick A. Dick, Nageswara Rao Dunna, R.L. Akshaya, Nikhil C. Munshi, Mehmet Samur, Masood A. Shammas, Rao Prabhala, Subodh Kumar, Mariateresa Fulciniti and Alison L. Martens and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Srikanth Talluri

44 papers receiving 696 citations

Peers

Srikanth Talluri

ONCOL

HEMAT

IMMUN

Andrea Pelosi Italy

Scott R. Dalton United States

Joydeep Bhadury Sweden

Joanne I. Hsu United States

Wade Anderson United States

Anne‐Lise Børresen‐Dale Norway

Saki Paul India

Qian Zhu China

Karel Fostier Belgium

Sharl Azar United States

Andrea Pelosi Italy

Srikanth Talluri

489 ×1.0

202 ×0.8

ONCOL

300 ×1.4

81 ×0.8

HEMAT

297 ×3.6

IMMUN

Citations per year, relative to Srikanth Talluri Srikanth Talluri (= 1×) peers Andrea Pelosi

Countries citing papers authored by Srikanth Talluri

Since Specialization

Citations

This map shows the geographic impact of Srikanth Talluri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Srikanth Talluri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Srikanth Talluri more than expected).

Fields of papers citing papers by Srikanth Talluri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Srikanth Talluri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Srikanth Talluri. The network helps show where Srikanth Talluri may publish in the future.

Co-authorship network of co-authors of Srikanth Talluri

This figure shows the co-authorship network connecting the top 25 collaborators of Srikanth Talluri. A scholar is included among the top collaborators of Srikanth Talluri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Srikanth Talluri. Srikanth Talluri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Samur, Anıl Aktaş, Jill Corre, Srikanth Talluri, et al.. (2025). Genomically Smoldering Multiple Myeloma Is Not a Distinct Entity But a Collection of Monoclonal Gammopathy of Undetermined Significance or Multiple Myeloma. Journal of Clinical Oncology. 44(4). 321–334.

Talluri, Srikanth, et al.. (2025). Xenobiotic metabolizing gene polymorphisms and their influence on ovarian cancer susceptibility: A Case-Control and an in silico approach. Molecular Biology Reports. 52(1). 906–906.

Talluri, Srikanth, Moritz Binder, Eugenio Morelli, et al.. (2025). Loss of BCL7A permits IRF4 transcriptional activity and cellular growth in multiple myeloma. Blood. 146(1). 104–114. 1 indexed citations

Talluri, Srikanth, et al.. (2024). Genomic instability in ovarian cancer: Through the lens of single nucleotide polymorphisms. Clinica Chimica Acta. 565. 119992–119992.

Kumar, Subodh, Srikanth Talluri, Leutz Buon, et al.. (2023). ABL1 kinase plays an important role in spontaneous and chemotherapy-induced genomic instability in multiple myeloma. Blood. 143(11). 996–1005. 3 indexed citations

Chyra, Zuzana, Sigitas Verselis, Ivane Abiatari, et al.. (2023). Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics. Blood Cancer Journal. 13(1). 23–23. 3 indexed citations

Talluri, Srikanth, et al.. (2023). RAD51 Is Required for the Occupancy of Replication Licensing Factors on the Myeloma Genome. Blood. 142(Supplement 1). 6587–6587. 1 indexed citations

Kumar, Subodh, Srikanth Talluri, Leutz Buon, et al.. (2023). Elevated APE1 Dysregulates Homologous Recombination and Cell Cycle Driving Genomic Evolution, Tumorigenesis, and Chemoresistance in Esophageal Adenocarcinoma. Gastroenterology. 165(2). 357–373. 7 indexed citations

Talluri, Srikanth, et al.. (2022). Homologous recombination DNA repair gene RAD51, XRCC2 & XRCC3 polymorphisms and breast cancer risk in South Indian women. PLoS ONE. 17(1). e0259761–e0259761. 9 indexed citations

10.

Gullà, Annamaria, Eugenio Morelli, Mehmet Samur, et al.. (2021). Bortezomib Induces Anti–Multiple Myeloma Immune Response Mediated by cGAS/STING Pathway Activation. Blood Cancer Discovery. 2(5). 468–483. 92 indexed citations

11.

Arunachalam, J., et al.. (2021). Impact of xenobiotic-metabolizing gene polymorphisms on breast cancer risk in South Indian women. Breast Cancer Research and Treatment. 186(3). 823–837. 7 indexed citations

12.

Arunachalam, J., et al.. (2020). DNA repair genes hOGG1, XRCC1 and ERCC2 polymorphisms and their molecular mapping in breast cancer patients from India. Molecular Biology Reports. 47(7). 5081–5090. 6 indexed citations

13.

Akshaya, R.L., et al.. (2020). Association of HOTAIR (rs920778 and rs1899663) and NME1 (rs16949649 and rs2302254) gene polymorphisms with breast cancer risk in India. Gene. 762. 145033–145033. 14 indexed citations

14.

Alagpulinsa, David A., Subodh Kumar, Srikanth Talluri, et al.. (2019). Amplification and overexpression of E2 ubiquitin conjugase UBE2T promotes homologous recombination in multiple myeloma. Blood Advances. 3(23). 3968–3972. 12 indexed citations

15.

Talluri, Srikanth, Mehmet Samur, Leutz Buon, et al.. (2017). Apobec Family of Proteins Mediate Genomic Changes in Multiple Myeloma By Inducing DNA Damage and C>T Mutations. Blood. 130. 4334–4334. 1 indexed citations

16.

Jensen, Michael D., Srikanth Talluri, Paula J. Foster, et al.. (2015). Technical Note: Immunohistochemical evaluation of mouse brain irradiation targeting accuracy with 3D‐printed immobilization device. Medical Physics. 42(11). 6507–6513. 12 indexed citations

17.

Ishak, Charles A., David Gallo, Aren E. Marshall, et al.. (2014). Haploinsufficiency of an RB–E2F1–Condensin II Complex Leads to Aberrant Replication and Aneuploidy. Cancer Discovery. 4(7). 840–853. 60 indexed citations

18.

Cecchini, Matthew J., Srikanth Talluri, James I. MacDonald, et al.. (2014). A Retinoblastoma Allele That Is Mutated at Its Common E2F Interaction Site Inhibits Cell Proliferation in Gene-Targeted Mice. Molecular and Cellular Biology. 34(11). 2029–2045. 28 indexed citations

19.

Talluri, Srikanth & Frederick A. Dick. (2013). The retinoblastoma protein and PML collaborate to organize heterochromatin and silence E2F-responsive genes during senescence. Cell Cycle. 13(4). 641–651. 16 indexed citations

20.

Talluri, Srikanth & Frederick A. Dick. (2012). Regulation of transcription and chromatin structure by pRB: Here, there and everywhere. Cell Cycle. 11(17). 3189–3198. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact